Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.47 USD | +0.34% | +1.40% | +59.05% |
May. 10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
May. 09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 21.23 | 21.23 | 19.52 |
Spread/Res. | -18.04% | -18.04% | -10.86% |
Spread/Supp. | +15.38% | +56.62% | +74.00% |
Support | 15.08 | 11.11 | 10.00 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- EWTX Stock
- Charts Edgewise Therapeutics, Inc.